Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00244803 · ClinicalTrials.gov registry record
Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 101
- Enrollment target
NCT00244803: Completed study, sponsored by Johns Hopkins University.
NCT00244803 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00244803 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00244803
The ClinicalTrials.gov registry entry for NCT00244803 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00244803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00244803 about?
NCT00244803 is a clinical study titled "Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)". The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.
What is the current status of trial NCT00244803?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2005-01. Estimated completion is 2007-05.
Who is sponsoring clinical trial NCT00244803?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.